The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions
Open accessAbstract
The COVID-19-, SARS- and MERS-related coronaviruses share many genomic and structural similarities. However, the SARS-CoV-2 is less pathogenic than SARS-CoV and MERS-CoV. Despite some differences in the cytokine patterns, it seems that the cytokine storm plays a crucial role in the pathogenesis of COVID-19-, SARS- and MERS. Monocytes and macrophages may be infected by SARS-CoV-2 through ACE2-dependent and ACE2-independent pathways. SARS-CoV-2 can effectively suppress the anti-viral IFN response in monocytes and macrophages. Since macrophages and dendritic cells (DCs) act as antigen presenting cells (APCs), the infection of these cells by SARS-CoV-2 impairs the adaptive immune responses against the virus. Upon infection, monocytes migrate to the tissues where they become infected resident macrophages, allowing viruses to spread through all organs and tissues. The SARS-CoV-2-infected monocytes and macrophages can produce large amounts of numerous types of pro-inflammatory cytokines and chemokines, which contribute to local tissue inflammation and a dangerous systemic inflammatory response called cytokine storm. Both local tissue inflammation and the cytokine storm play a fundamental role in the development of COVID-19-related complications, such as acute respiratory distress syndrome (ARDS), which is a main cause of death in COVID-19 patients. Here, we describe the monocytes and macrophage responses during severe coronavirus infections, while highlighting potential therapeutic interventions to attenuate macrophage-related inflammatory reactions in possible approaches for COVID-19 treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Rothan, H. A., & Byrareddy, S. N. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102433 · Cited by 5,840
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Baig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00122 · Cited by 2,207
COVID-19 pathophysiology: A review
Yuki, K., Fujiogi, M., & Koutsogiannaki, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108427 · Cited by 2,206
Molecular immune pathogenesis and diagnosis of COVID-19
Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.03.001 · Cited by 1,721
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
Wang, K., Chen, W., Zhang, Z., Deng, Y., Lian, J.-Q., Du, P., Wei, D., Zhang, Y., Sun, X.-X., Gong, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00426-x · Cited by 1,593
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic
(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0772 · Cited by 1,537 · cited 20×
“Aviptadil Vasoactive intestinal polypeptide (VIP) – ARDS, ALI, Dyspnea, COVID-19 Repurposing, Clinical Trial (NCT04360096).”
InfluentialRies, C. H., Cannarile, M. A., Hoves, S., Benz, J., Wartha, K., Runza, V., Rey-Giraud, F., Pradel, L. P., Feuerhake, F., Klaman, I., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.016 · Cited by 1,384
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., Qi, Y., Sun, R., Tian, Z., Xu, X., & Wei, H. (2020) · National Science Review · doi:10.1093/nsr/nwaa041 · Cited by 1,295
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG, C. K., LAM, C. W. K., WU, A. K. L., IP, W. K., LEE, N. L. S., CHAN, I. H. S., LIT, L. C. W., HUI, D. S. C., CHAN, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,274
COVID-19, SARS and MERS: are they closely related?
Petrosillo, N., Viceconte, G., Ergonul, O., Ippolito, G., & Petersen, E. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.03.026 · Cited by 1,108
Lung pathology of fatal severe acute respiratory syndrome
Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M., Hui, P. K., Mak, K. L., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13413-7 · Cited by 1,076
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China
Yang, Y., Peng, F., Wang, R., Guan, K., Jiang, T., Xu, G., Sun, J., & Chang, C. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102434 · Cited by 1,068
[A pathological report of three COVID-19 cases by minimal invasive autopsies].
Yao, X. H., Li, T. Y., He, Z. C., Ping, Y. F., Liu, H. W., Yu, S. C., Mou, H. M., Wang, L. H., Zhang, H. R., Fu, W. J., et al. (2020) · PubMed · doi:10.3760/cma.j.cn112151-20200312-00193 · Cited by 963
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
Harmer, D., Gilbert, M., Borman, R., & Clark, K. L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03640-2 · Cited by 852
Liu, L., Wei, Q., Lin, Q., Fang, J., Wang, H., Kwok, H., Tang, H., Nishiura, K., Peng, J., Tan, Z., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123158 · Cited by 830 · cited 5×
“The adoptive transfer of the anti-S IgG to macaques reduces viral loads after subsequent challenge with SARSCoV but caused significant alveolar damage than the control animals [70].”
InfluentialThe Science Underlying COVID-19: Implications for the Cardiovascular System
Liu, P. P., Blet, A., Smyth, D., & Li, H. (2020) · Circulation · doi:10.1161/circulationaha.120.047549 · Cited by 800
Fu, Y., Cheng, Y., & Wu, Y. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00207-4 · Cited by 788
Li, X., Yao, W., Yuan, Y., Chen, P., Li, B., Li, J., Chu, R., Song, H., Xie, D., Jiang, X., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310514 · Cited by 737
Lambert, D. W., Yarski, M., Warner, F. J., Thornhill, P., Parkin, E. T., Smith, A. I., Hooper, N. M., & Turner, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505111200 · Cited by 694
The role of biomarkers in diagnosis of COVID-19 – A systematic review
Kermali, M., Khalsa, R. K., Pillai, K., Ismail, Z., & Harky, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117788 · Cited by 687
Jamilloux, Y., Henry, T., Belot, A., Viel, S., Fauter, M., El Jammal, T., Walzer, T., François, B., & Sève, P. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102567 · Cited by 658
COVID-19: A promising cure for the global panic
Vellingiri, B., Jayaramayya, K., Iyer, M., Narayanasamy, A., Govindasamy, V., Giridharan, B., Ganesan, S., Venugopal, A., Venkatesan, D., Ganesan, H., et al. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138277 · Cited by 636
COVID-19: Melatonin as a potential adjuvant treatment
Zhang, R., Wang, X., Ni, L., Di, X., Ma, B., Niu, S., Liu, C., & Reiter, R. J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117583 · Cited by 619
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
Jeffers, S. A., Tusell, S. M., Gillim-Ross, L., Hemmila, E. M., Achenbach, J. E., Babcock, G. J., Thomas, W. D., Thackray, L. B., Young, M. D., Mason, R. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403812101 · Cited by 605
SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview
Rabaan, A. A., Al-Ahmed, S. H., Haque, S., Sah, R., Tiwari, R., Malik, Y. S., Dhama, K., Yatoo, M. I., Bonilla‐Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · PubMed · Cited by 592
Tseng, C.-T., Sbrana, E., Iwata-Yoshikawa, N., Newman, P. C., Garron, T., Atmar, R. L., Peters, C. J., & Couch, R. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035421 · Cited by 561
Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
Chen, I.-Y., Moriyama, M., Chang, M.-F., & Ichinohe, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00050 · Cited by 547
Snijder, E. J., van der Meer, Y., Zevenhoven-Dobbe, J., Onderwater, J. J. M., van der Meulen, J., Koerten, H. K., & Mommaas, A. M. (2006) · Journal of Virology · doi:10.1128/jvi.02501-05 · Cited by 512
Immunopathogenesis of coronavirus infections: implications for SARS
Dandekar, A. A., & Perlman, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1732 · Cited by 499
Yang, Z.-Y., Huang, Y., Ganesh, L., Leung, K., Kong, W.-P., Schwartz, O., Subbarao, K., & Nabel, G. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5642-5650.2004 · Cited by 490
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
Lokugamage, K. G., Hage, A., de Vries, M., Valero-Jimenez, A. M., Schindewolf, C., Dittmann, M., Rajsbaum, R., & Menachery, V. D. (2020) · Journal of Virology · doi:10.1128/jvi.01410-20 · Cited by 483
Bolles, M., Deming, D., Long, K., Agnihothram, S., Whitmore, A., Ferris, M., Funkhouser, W., Gralinski, L., Totura, A., Heise, M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06048-11 · Cited by 477 · cited 1×
“Similar observations concerning the SARS-CoV vaccine-induced lung damages have also been reported in mice and African green monkeys [71,72].”
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
Sarzi-Puttini, P., Giorgi, V., Sirotti, S., Marotto, D., Ardizzone, S., Rizzardini, G., Antinori, S., & Galli, M. (2020) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/xcdary · Cited by 466
Cheung, C. Y., Poon, L. L. M., Ng, I. H. Y., Luk, W., Sia, S.-F., Wu, M. H. S., Chan, K.-H., Yuen, K.-Y., Gordon, S., Guan, Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7819-7826.2005 · Cited by 461
Konno, Y., Kimura, I., Uriu, K., Fukushi, M., Irie, T., Koyanagi, Y., Sauter, D., Gifford, R. J., Nakagawa, S., & Sato, K. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108185 · Cited by 433
Zhou, J., Chu, H., Li, C., Wong, B. H.-Y., Cheng, Z.-S., Poon, V. K.-M., Sun, T., Lau, C. C.-Y., Wong, K. K.-Y., Chan, J. Y.-W., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit504 · Cited by 428
Franks, T. J., Chong, P. Y., Chui, P., Galvin, J. R., Lourens, R. M., Reid, A. H., Selbs, E., Mcevoy, C. P. L., Hayden, C. D. L., Fukuoka, J., et al. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00367-8 · Cited by 415
IL-10: A Multifunctional Cytokine in Viral Infections
Rojas, J. M., Avia, M., Martín, V., & Sevilla, N. (2017) · Journal of Immunology Research · doi:10.1155/2017/6104054 · Cited by 408
Alveolar Macrophages Are the Primary Interferon-α Producer in Pulmonary Infection with RNA Viruses
Kumagai, Y., Takeuchi, O., Kato, H., Kumar, H., Matsui, K., Morii, E., Aozasa, K., Kawai, T., & Akira, S. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.013 · Cited by 394
Lau, S. K. P., Lau, C. C. Y., Chan, K.-H., Li, C. P. Y., Chen, H., Jin, D.-Y., Chan, J. F. W., Woo, P. C. Y., & Yuen, K.-Y. (2013) · Journal of General Virology · doi:10.1099/vir.0.055533-0 · Cited by 392
Drosten, C., Seilmaier, M., Corman, V. M., Hartmann, W., Scheible, G., Sack, S., Guggemos, W., Kallies, R., Muth, D., Junglen, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70154-3 · Cited by 387
Zhang, D., Guo, R., Lei, L., Liu, H., Wang, Y., Wang, Y., Qian, H., Dai, T., Zhang, T., Lai, Y., et al. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.4hi0720-470r · Cited by 383
The discovery of angiotensin‐converting enzyme 2 and its role in acute lung injury in mice
Imai, Y., Kuba, K., & Penninger, J. M. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.040048 · Cited by 334
M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds
Wang, Y., Smith, W., Hao, D., He, B., & Kong, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.050 · Cited by 330
Targeting the “Cytokine Storm” for Therapeutic Benefit
D'Elia, R. V., Harrison, K., Oyston, P. C., Lukaszewski, R. A., & Clark, G. C. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00636-12 · Cited by 324
Jaume, M., Yip, M. S., Cheung, C. Y., Leung, H. L., Li, P. H., Kien, F., Dutry, I., Callendret, B., Escriou, N., Altmeyer, R., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00671-11 · Cited by 314
Rana, A. K., Li, Y., Dang, Q., & Yang, F. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.016 · Cited by 303
Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response
Kindler, E., Thiel, V., & Weber, F. (2016) · Advances in Virus Research · doi:10.1016/bs.aivir.2016.08.006 · Cited by 290
Spiegel, M., Pichlmair, A., Martínez-Sobrido, L., Cros, J., García-Sastre, A., Haller, O., & Weber, F. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2079-2086.2005 · Cited by 279
Agrawal, A. S., Tao, X., Algaissi, A., Garron, T., Narayanan, K., Peng, B.-H., Couch, R. B., & Tseng, C.-T. K. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1177688 · Cited by 274
The immune system and COVID-19: Friend or foe?
Yazdanpanah, F., Hamblin, M. R., & Rezaei, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117900 · Cited by 270
Type I IFN immunoprofiling in COVID-19 patients
Trouillet-Assant, S., Viel, S., Gaymard, A., Pons, S., Richard, J.-C., Perret, M., Villard, M., Brengel-Pesce, K., Lina, B., Mezidi, M., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.029 · Cited by 265
The Mononuclear Phagocyte System: The Relationship between Monocytes and Macrophages
Hume, D. A., Irvine, K. M., & Pridans, C. (2019) · Trends in Immunology · doi:10.1016/j.it.2018.11.007 · Cited by 264
Broxmeyer, H. E., Sherry, B., Cooper, S., Lu, L., Maze, R., Beckmann, M. P., Cerami, A., & Ralph, P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.8.3448 · Cited by 260
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
Yip, M. S., Leung, N. H. L., Cheung, C. Y., Li, P. H., Lee, H. H. Y., Daëron, M., Peiris, J. S. M., Bruzzone, R., & Jaume, M. (2014) · Virology Journal · doi:10.1186/1743-422x-11-82 · Cited by 250
Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
Faure, E., Poissy, J., Goffard, A., Fournier, C., Kipnis, E., Titecat, M., Bortolotti, P., Martinez, L., Dubucquoi, S., Dessein, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088716 · Cited by 248
Wang, W., Ye, L., Ye, L., Li, B., Gao, B., Zeng, Y., Kong, L., Fang, X., Zheng, H., Wu, Z., et al. (2007) · Virus Research · doi:10.1016/j.virusres.2007.02.007 · Cited by 247
Monocytes and Macrophages as Viral Targets and Reservoirs
Nikitina, E., Larionova, I., Choinzonov, E., & Kzhyshkowska, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092821 · Cited by 242
Weiss, R. C., & Scott, F. W. (1981) · Comparative Immunology, Microbiology and Infectious Diseases · doi:10.1016/0147-9571(81)90003-5 · Cited by 240
He, W., Kapate, N., Shields, C. W., & Mitragotri, S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.001 · Cited by 236
Dosch, S. F., Mahajan, S. D., & Collins, A. R. (2009) · Virus Research · doi:10.1016/j.virusres.2009.01.005 · Cited by 228
Q&A: The novel coronavirus outbreak causing COVID-19
Fisher, D., & Heymann, D. (2020) · BMC Medicine · doi:10.1186/s12916-020-01533-w · Cited by 226
Papadopoulos, K. P., Gluck, L., Martin, L. P., Olszanski, A. J., Tolcher, A. W., Ngarmchamnanrith, G., Rasmussen, E., Amore, B. M., Nagorsen, D., Hill, J. S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3261 · Cited by 210
Banu, N., Panikar, S. S., Leal, L. R., & Leal, A. R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117905 · Cited by 206
COVID-19 and emerging viral infections: The case for interferon lambda
Prokunina-Olsson, L., Alphonse, N., Dickenson, R. E., Durbin, J. E., Glenn, J. S., Hartmann, R., Kotenko, S. V., Lazear, H. M., O’Brien, T. R., Odendall, C., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200653 · Cited by 204
SARS-coronavirus replication in human peripheral monocytes/macrophages
Yilla, M., Harcourt, B. H., Hickman, C. J., McGrew, M., Tamin, A., Goldsmith, C. S., Bellini, W. J., & Anderson, L. J. (2005) · Virus Research · doi:10.1016/j.virusres.2004.09.004 · Cited by 190
Zhang, L., Zhang, F., Yu, W., He, T., Yu, J., Yi, C. E., Ba, L., Li, W., Farzan, M., Chen, Z., et al. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20499 · Cited by 186
Type I interferons: diversity of sources, production pathways and effects on immune responses
Swiecki, M. K., & Colonna, M. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.026 · Cited by 183
Chu, H., Zhou, J., Ho-Yin Wong, B., Li, C., Cheng, Z.-S., Lin, X., Kwok-Man Poon, V., Sun, T., Choi-Yi Lau, C., Fuk-Woo Chan, J., et al. (2014) · Virology · doi:10.1016/j.virol.2014.02.018 · Cited by 179
Global virus outbreaks: Interferons as 1st responders
Wang, B. X., & Fish, E. N. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101300 · Cited by 168
Ponzoni, M., Pastorino, F., Paolo, D. D., Perri, P., & Brignole, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071953 · Cited by 165
Mesel-Lemoine, M., Millet, J., Vidalain, P.-O., Law, H., Vabret, A., Lorin, V., Escriou, N., Albert, M. L., Nal, B., & Tangy, F. (2012) · Journal of Virology · doi:10.1128/jvi.00269-12 · Cited by 160
Pneumonia from Human Coronavirus in a Macaque Model
Munster, V. J., de Wit, E., & Feldmann, H. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1215691 · Cited by 143
Pandey, A., Nikam, A. N., Shreya, A. B., Mutalik, S. P., Gopalan, D., Kulkarni, S., Padya, B. S., Fernandes, G. J., Mutalik, S., & Prassl, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117883 · Cited by 139
Targeting Macrophages: Friends or Foes in Disease?
Ardura, J. A., Rackov, G., Izquierdo, E., Alonso, V., Gortázar, A. R., & Escribese, M. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01255 · Cited by 134
Scheuplein, V., Seifried, J., Malczyk, A. H., Miller, L., Höcker, L., Vergara‐Alert, J., Dolnik, O., Zielecki, F., Becker, B., Spreitzer, I., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03607-14 · Cited by 132
Macrophage Polarization in Virus-Host Interactions
Miller, Y. S. L. C. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000311 · Cited by 123
SARS-CoV Regulates Immune Function-Related Gene Expression in Human Monocytic CellsPreprint
Hu, W., Yen, Y.-T., Singh, S., Kao, C., & Wu‐Hsieh, B. A. (2011) · Nature Precedings · doi:10.1089/vim.2011.0099 · Cited by 115
Hohdatsu, T., Yamada, M., TOMINAGA, R., MAKINO, K., Kida, K., & Koyama, H. (1998) · Journal of Veterinary Medical Science · doi:10.1292/jvms.60.49 · Cited by 109
Page, C., Goicochea, L., Matthews, K. L., Zhang, Y., Klover, P. J., Holtzman, M. J., Hennighausen, L. G., & Frieman, M. B. (2012) · Journal of Virology · doi:10.1128/jvi.01689-12 · Cited by 108
Yan, T., Xiao, R., & Lin, G. (2020) · The FASEB Journal · doi:10.1096/fj.202000782 · Cited by 106
Jafarzadeh, A., Larussa, T., Nemati, M., & Jalapour, S. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.01.040 · Cited by 101
Self-citationSarris, A. H., Broxmeyer, H. E., Wirthmueller, U., Karasavvas, N., Cooper, S. H., Lu, L., Krueger, J. G., & Ravetch, J. V. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.3.1127 · Cited by 100
Inflammasome activation and Th17 responses
Deng, J. P., Yu, X., & Wang, P. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2018.12.024 · Cited by 98
Modulation of the immune response by Middle East respiratory syndrome coronavirus
Shokri, S., Mahmoudvand, S., Taherkhani, R., & Farshadpour, F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27155 · Cited by 94
Tynell, J., Westenius, V., Rönkkö, E., Munster, V. J., Melén, K., Österlund, P., & Julkunen, I. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000351 · Cited by 92
Zhou, J., Chu, H., Chan, J. F., & Yuen, K. (2015) · Virology Journal · doi:10.1186/s12985-015-0446-6 · Cited by 87
COVID-19: an Immunopathological View
Kadkhoda, K. (2020) · mSphere · doi:10.1128/msphere.00344-20 · Cited by 85
Jafarzadeh, A., & Nemati, M. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.09.003 · Cited by 84
Self-citationZiegler, T. T., Matikainen, S., Rönkkö, E., Österlund, P., Sillanpää, M., Sirén, J., Fagerlund, R., Immonen, M., Melén, K., & Julkunen, I. (2005) · Journal of Virology · doi:10.1128/jvi.79.21.13800-13805.2005 · Cited by 83
Drug repurposing against COVID-19: focus on anticancer agents
Ciliberto, G., Mancini, R., & Paggi, M. G. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01590-2 · Cited by 81
Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract
Andreakos, E., Salagianni, M. L., Galani, I. E., & Koltsida, O. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01232 · Cited by 77
Ortega, R. A., Barham, W. J., Sharman, K., Tikhomirov, O., Giorgio, T. D., & Yull, F. E. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s93483 · Cited by 76
Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection
Nemati, M., Larussa, T., Khorramdelazad, H., Mahmoodi, M., & Jafarzadeh, A. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.04.006 · Cited by 75
Self-citationShirey, K. A., Lai, W., Pletneva, L. M., Karp, C. L., Divanovic, S., Blanco, J. C. G., & Vogel, S. N. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.71 · Cited by 73
Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice
Pedersen, K. B., Chodavarapu, H., Porretta, C. P., Robinson, L. K., & Lazartigues, E. D. (2015) · Endocrinology · doi:10.1210/en.2015-1556 · Cited by 51
Middle East Respiratory Syndrome: Pathogenesis and Therapeutic Developments
Choudhry, H., Bakhrebah, M. A., Abdulaal, W. H., Zamzami, M. A., Baothman, O. A. S., Hassan, M., Zeyadi, M., Helmi, N. M., Alzahrani, F. A., Ali, A., et al. (2019) · Future Virology · doi:10.2217/fvl-2018-0201 · Cited by 41
Transcriptional control of macrophage polarisation in type 2 diabetes
Drareni, K., Gautier, J., Venteclef, N., & Alzaïd, F. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00748-1 · Cited by 40
Jafarzadeh, A., Nemati, M., & Jafarzadeh, S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116688 · Cited by 40
Self-citationImmune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2
İnandıklıoğlu, N., & Akkoç, T. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_549 · Cited by 37
Human Leukocyte Antigens Influence the Antibody Response to Hepatitis B Vaccine.
Jafarzadeh, A., Bagheri-Jamebozorgi, M., Nemati, M., Golsaz‐Shirazi, F., & Shokri, F. (2015) · PubMed · Cited by 16
Self-citation
Cited by
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
Vogel, A. B., Kanevsky, I., Che, Y., Swanson, K. A., Muik, A., Vormehr, M., Kranz, L. M., Walzer, K. C., Hein, S., Güler, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03275-y · Cited by 694
Patterson, B. K., Francisco, E. B., Yogendra, R., Long, E., Pise, A., Rodrigues, H., Hall, E., Herrera, M., Parikh, P., Guevara-Coto, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746021 · Cited by 280
Vogel, A. B., Kanevsky, I., Che, Y., Swanson, K. A., Muik, A., Vormehr, M., Kranz, L. M., Walzer, K. C., Hein, S., Güler, A., et al. (2020) · doi:10.1101/2020.09.08.280818 · Cited by 126
Metadata
- Authors
- Jafarzadeh, A., Chauhan, P., Saha, B., Jafarzadeh, S., & Nemati, M.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 257
- Pages
- 118102
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W3043083362
- Cited by
- 327
- References
- 116
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.